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Metal complexing ability 
Structure-anticancer activity relationship 
A B S T R A C T
We recently described a novel class of thiosemicarbazones (TSCs) with a high anticancer activity. Now, we 
expanded this compound library with a new class of TSCs with a 3-nitro-1,8-naphthalene unit. Thus, a series of 
novel TSC conjugates was obtained to determine the effect of its chemical structure on spectroscopic properties, 
metal complexing and biological activity. They were prepared in a microwave reactor, provided compounds with 
both a high yield and purity. Nuclear magnetic resonance (1H and 13C NMR, COSY, HMQC) and infrared 
spectroscopy were used to characterize them structurally. Additionally, DFT calculations were performed in 
order to obtain the optimized ground-state geometry. Physicochemical spectroscopic studies were conducted in 
different solvents and conditions to assess the effect of the substituent on the optical properties and metal 
complexing ability. The anticancer activity was tested on three cancer cell lines and then correlated with the 
spectroscopic results. Here, we show based on in vitro chelating studies, that anticancer activity is closely 
correlated with the Fe3+ and Cu2+ chelating ability of these compounds.   
1. Introduction
Because iron and copper are important for the proper functioning of
cells, new chelators that target these microelements are of substantial 
interest for contemporary medicinal chemistry [1]. Thiosemicarbazones 
(TSCs) are a class of compounds that have a broad spectrum of biological 
activity [2–8]. In particular, their antitumor activity is often associated 
with metal chelating ability, which controls the bioavailability of these 
metals [9,10]. Moreover, ligand-metal complexes are potential sources 
of free radicals. TSC complexation can also affect important cellular 
processes such as cell cycle inhibition and the deactivation of the ribo-
nucleotide reductase (RR) enzyme [11,12]. In particular, this refers to a 
function of cancer cells [13]. Different oxidation states determine the 
behavior of metals, which are reactive in redox reactions. Metal coor-
dination by the TSC ligand does not saturate the coordination sphere and 
therefore oxidation/reduction is still possible [9], while a specific 
coordination manner enables a switch of an electron [2]. TSC ligands, 
which leave gaps in the coordination sphere, generate reactive oxygen 
species (ROS) responsible for the anticancer mechanism of action [14]. 
An increase of the complexing properties of TSCs could potentially 
enhance their antitumor activity [15]. In this regard, we carefully tested 
the complexing behavior of a series of TSC compounds that have a high 
anticancer activity [12,16–19]. Moreover, the TSC structures were 
modified by introducing 3-nitro-1,8-naphthaliimide into the TSC scaf-
fold in order to analyze the effect of this moiety on the metal complexing 
properties. The naphthalimide scaffold can often bind to DNA via 
intercalation [19–23], which is often of substantial importance for the 
anticancer activity of a variety of drugs. In particular, cytotoxic prop-
erties have been demonstrated for 3-nitro-1,8-naphthalimides, which 
contain a six-membered saturated heterocyclic such as piperazine, 
morpholine or piperidine [24]. 
The antitumor activity of the new TSCs with the piperazine, 
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morpholine or piperidine fragments was described in our previous 
publications [12,16–19]. Herein, we expanded this compound library 
with a new class of TSCs with a 3-nitro-1,8-naphthalene unit (NIT), 
which was obtained by condensing thiosemicarbazides with 3-nitro-1, 
8-naphthalic acid anhydride. In the literature, there is very little infor-
mation on similar compounds [25,26] that were synthesized in a reac-
tion of 2-amino-benzo[de]isoquinolin-1,3-dione with the corresponding 
isothiocyanides [25]. We show that the anticancer activity of the TSCs 
are closely related to their chelating ability. Accordingly, unlike TSCs, 
which appeared to be a strong complexing agent against Fe3+ and Cu2+, 
the complexing and anticancer activity of the NITs were negligible. 
2. Experimental section 
2.1. Materials and methods 
The 1H, 13C NMR and 2d correlation spectra (HMQC, COSY) were 
recorded on either a Bruker AC400 or Ascend™ 500 spectrometer. The 
FT-IR measurements were taken using a Nicolet iS5 FT-IR with a spectral 
range of 400− 4000 cm− 1. The mass spectra of the TSCs were recorded 
using a Varian 500-MS IT mass spectrometer (LR-MS (ESI)). The UV–vis 
absorption spectra were measured using an Evolution™ 200 UV–vis 
spectrophotometer for a compound concentration of 10 μM and a 1 cm 
quartz cell. The melting point was determined using OptiMelt. All of the 
chemicals and starting materials were commercially available and were 
used without any further purification. The NMR solvents were pur-
chased from ACROS Organics. The metal salts that were used in the 
UV–vis surveys were prepared from the corresponding chloride salts and 
were analytical grade. The solvents for the spectroscopy such as chlo-
roform (CHCl3 – Chempur), methanol (MeOH – Acros Organic), aceto-
nitrile (ACN – Acros Organic) and dimethyl sulfoxide (DMSO – 
Chempur) were used to investigate the absorption properties. 
2.2. Synthesizing the thiosemicarbazones 
The general procedure for synthesis of 3-nitro-1,8-naphthalimide 
(NITs 1-9) derivatives and the spectral characteristics (1H, 13C NMR 
and FT-IR) for the compounds that were obtained is described below. 
General synthesis of the NIT 
A 3-nitro-1,8-naphthalic anhydride (0.25 mmol) with the appro-
priate thiosemicarbazide (0.25 mmol, Tc: 1-9) was introduced into a 
tube. Then, 15 mL of ethanol was added, and the tube was sealed with a 
septum. The reaction was conducted in a microwave reactor for 20 min 
at 80 ◦C, 40 W. Next, the mixture was cooled, filtered and washed with 
ethanol. Then, the product was crystallized from ethyl acetate. 
NIT-1: 
Product in the form of a yellow powder, yield: 59 %; mp: 
275− 276 ◦C; 1H NMR (500 MHz, d6-DMSO, ppm) δ 10.60 (s, 1 H), 9.56 
(d, J = 2.0 Hz, 1 H), 9.02 (d, J = 2.1 Hz, 1 H), 8.87 (d, J = 8.2 Hz, 1 H), 
8.75 (d, J = 6.8 Hz, 1 H), 8.12 (t, J = 7.8 Hz, 1 H), 7.62 (d, J = 8.8 Hz, 
2 H), 7.03 (d, J = 8.9 Hz, 2 H), 4.15 (m, 4 H), 3.59 (m, 4 H). 13C NMR 
(126 MHz, d6-DMSO, ppm) δ 183.19, 161.67, 161.29, 152.84, 146.45, 
137.63, 135.18, 133.83, 131.70, 130.99, 129.93, 129.77, 124.29, 
124.15, 122.81, 120.54, 113.96, 98.61, 48.05, 45.62; FT-IR (KBr, ν, cm- 
1): 3447 (N–H…O); 3285 (N–H); 3110− 2940 (C–H aromatic); 
2940− 2750 (C–H, aliphatic); 1725 and 1690 (C–O imide); 1606 
(N–O); 1540 (N–H); 1520 (C–C aromatic). 
NIT-2: 
Product in the form of a yellow powder, yield: 75 %; mp: 
245− 246 ◦C; 1H NMR (500 MHz, d6-DMSO, ppm) δ 10.61 (s, 1 H), 9.57 
(d, J = 2.3 Hz, 1 H), 9.02 (d, J = 2.3 Hz, 1 H), 8.88 (dd, 1 H), 877–8.75 
(m, 1 H), 8.12 (dd, 1 H); 7.29–7.26 (m, 2 H), 7.04–7.00 (m, 2 H), 
4.15–4.11 (m, 4 H), 3.32 (s, 4 H). 13C NMR (126 MHz, d6-DMSO, ppm) δ 
183.25, 161.96, 161.30, 149.65, 146.47, 137.63, 135.18, 131.71, 
130.99, 129.93, 129.78, 129.18, 124.29, 124.17, 123.12, 122.83, 
117.32, 48.57, 47.84. FT-IR (KBr, ν, cm-1): 3445 (N–H…O); 3357 
(N–H); 3110− 2940 (C–H, aromatic); 2940− 2750 (C–H, aliphatic); 
1731 and 1696 (C–O, imide); 1598 (N–O); 1539 (N–H); 1496 (C–C, 
aromatic). 
NIT-3: 
Product in the form of a yellow powder, yield: 73 %; mp: 
220− 221 ◦C; 1H NMR (500 MHz, d6-DMSO) δ 10.45 (s, 1 H), 9.58 (d, 
J = 2.3 Hz, 1 H), 9.04 (d, J = 2.3 Hz, 1 H), 8.91–8.86 (m, 1 H), 8.77 
(dd, 1 H), 8.15–8.11 (m, 1 H), 7.38–7.32 (m, 2 H), 7.30 (m, 2 H), 7.24 
(m, 1 H), 4.89 (d, J = 11.9 Hz, 2 H), 3.30 (m, 2 H), 2.96 (m, 1 H), 1.93 
(m, 2 H), 1.77–1.69 (m, 2 H). 13C NMR (126 MHz, d6-DMSO) δ 182.83, 
161.77, 161.36,146.49, 145.71, 137.91, 135.17, 131.72, 131.06, 
129.94, 129.83, 129.01, 127.17, 126.81. 124.30, 124.23, 122.91, 49.90, 
41.87, 33.11; FT-IR (KBr, ν, cm-1): 3439 (N–H…O); 3335 (N–H); 
3110− 2940 (C–H, aromatic); 2940− 2750 (C–H, aliphatic); 1729 and 
1697 (C–O, imide); 1595 (N–O); 1543 (N–H); 1505 (C–C aromatic). 
NIT-4: 
Product in the form of a yellow powder, yield: 43 %; mp: 
266− 258 ◦C; 1H NMR (500 MHz, d6-DMSO, ppm) δ 10.61 (s, 1 H), 9.58 
(d, J = 2.3 Hz, 1 H), 9.03 (d, J = 2.3 Hz, 1 H), 8.88 (dd, 1 H), 8.76 (dd, 
1 H), 8.62 (dd, 1 H), 8.26 (m, 1 H), 8.16–8.11 (m, 1 H), 4.17–4.13 (m, 
4 H), 3.70–3.67 (m, 4 H). 13C NMR (126 MHz, d6-DMSO, ppm) δ 183.60, 
161.67, 161.29, 159.59, 146.48, 143.78, 137.64, 137.21, 135.18, 
131.72, 131.00, 129.94, 127.19, 125.16, 124.30, 124.18, 122.89, 
122.84, 120.18, 119.29, 119.06, 48.53, 47.95. FT-IR (KBr, ν, cm-1): 
3431 (N–H…O); 3193 (N–H); 3110− 2940 (C–H aromatic); 
2940− 2750 (C–H, aliphatic); 1728 and 1699 (C–O imide); 1611 
(N–O); 1599 (N–H); 1539 (C–C, aromatic). 
NIT-5: 
Product in the form of a yellow powder, yield: 56 %; mp: 
271− 272 ◦C; 1H NMR (500 MHz, d6-DMSO, ppm) δ 10.58 (s, 1 H), 9.57 
(d, J = 2.3 Hz, 1 H), 9.03 (d, J = 2.3 Hz, 1 H), 8.88 (d, J = 8.3 Hz, 1 H), 
8.75 (d, J = 7.3 Hz, 1 H), 8.43 (d, J = 4.8 Hz, 2 H), 8.12 (m, 1 H), 6.71 
(t, J = 4.8 Hz, 1 H), 4.12–4.09 (m, 4 H), 3.90 (m, 4 H). 13C NMR 
(126 MHz, d6-DMSO, ppm) δ 183.35, 161.68, 161.46, 161.29, 158.49, 
146.47, 137.61, 135.17, 131.71, 130.98, 129.93, 129.78, 124.29, 
124.18, 122.84, 111.06, 48.51, 43.09; FT-IR (KBr, ν, cm-1): 3423 
(N–H…O); 3222 (N–H); 3110− 2940 (C–H, aromatic); 2940− 2750 
(C–H, aliphatic); 1725 and 1685 (C–O, imide); 1591 (N–O); 1555 
(N–H); 1539 (C–C, aromatic). 
NIT-6: 
Product in the form of a yellow powder, yield: 54 %; mp: 
249− 250 ◦C; 1H NMR (500 MHz, d6-DMSO, ppm) δ 10.58 (s, 1 H), 9.57 
(d, J = 2.3 Hz, 1 H), 9.02 (d, J = 2.3 Hz, 1 H), 8.88 (dd, 1 H), 8.75 (dd, 
1 H), 8.16 (m, 1 H), 8.14–8.10 (m, 1 H), 7.62–7.57 (m, 1 H), 6,88 (d, 
J = 8.6 Hz, 1 H), 6.68–6.67 (m, 1 H), 4.1–4.09 (m, 4 H), 3.73–3.68 (m, 
4 H). 13C NMR (126 MHz, d6-DMSO, ppm) δ 183.26, 161.69, 161.30, 
158.91, 148.05, 146.47, 138.13, 137.61, 135.17, 131.71, 130.98, 
129.93, 129.78, 124.29, 124.18, 122.84, 113.74, 107.53, 48.45, 44.20; 
FT-IR (KBr, ν, cm-1): 3439 (N–H…O); 3171 (N–H); 3110− 2940 (C–H 
aromatic); 2940− 2750 (C-H, aliphatic); 1728 and 1694 (C–O, imide); 
1599 (N–O); 1535 (N–H); 1504 (C–C aromatic). 
NIT-7: 
Product in the form of a yellow powder, yield: 78 %; mp: 
270− 273 ◦C; 1H NMR (500 MHz, d6-DMSO, ppm) δ 10.54 (s, 1 H), 9.56 
(d, J = 2.3 Hz, 1 H), 9.02 (d, J = 2.3 Hz, 1 H), 8.89–8.84 (m, 1 H), 8.75 
(dd, 1 H), 8.14–8.10 (m, 1 H), 3.99–3.94 (m, 4 H), 3.73 (dd, 4 H). 13C 
NMR (126 MHz, d6-DMSO, ppm) δ 183.60, 161.65, 161.27, 146.46, 
137.61, 135.16, 131.70, 130.97, 129.92, 129.77, 124.28, 124.17, 
122.82, 66.15, 49.45. FT-IR (KBr, ν, cm-1): 3445 (N–H…O); 3252 
(N–H); 3110− 2940 (C–H, aromatic); 2940− 2750 (C–H, aliphatic); 
1732 and 1677 (C–O, imide); 1596 (N–O); 1534 (N–H); 1511 (C–C 
aromatic). 
NIT-8: 
Product in the form of a yellow powder, yield: 81 %; mp: 
258− 260 ◦C; 1H NMR (500 MHz, d6-DMSO, ppm) δ 10.61 (s, 1 H), 9.58 
(d, J = 2.3 Hz, 1 H), 9.03 (d, J = 2.3 Hz, 1 H), 8.88 (dd, 1 H), 8.76 (dd, 
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1 H), 8.13 (dd, 1 H), 7.12–7.09 (m, 2 H), 7.06–7.02 (m, 2 H), 4.15–4.11 
(m, 4 H), 3.27–3.23 (m, 4 H). 13C NMR (126 MHz, d6-DMSO, ppm) δ 
183.26, 161.69, 161.33, 148.03, 146.48, 137.63, 135.18, 131.72, 
131.27, 129.94, 124.29, 124.18, 122.84, 117.92, 117.86, 115.96, 
115.78, 49.03, 48.80; FT-IR (KBr, ν, cm-1): 3497 (N–H…O); 3248 
(N–H); 3110− 2940 (C–H aromatic); 2940− 2750 (C–H aliphatic); 
1732 and 1676 (C–O imide); 1596 (N–O); 1537 (N–H); 1507 (C–C, 
aromatic). 
NIT-9: 
Product in the form of a yellow powder, yield: 61 %; mp. 
254− 256 ◦C; 1H NMR (500 MHz, d6-DMSO, ppm) δ 10.43 (s, 1 H), 9.57 
(d, J = 2.3 Hz, 1 H), 9.02 (d, J = 2.3 Hz, 1 H), 8.88 (dd, 1 H), 8.75 (dd, 
1 H), 8.12 (dd, J = 8.2, 7.5 Hz, 1 H), 3.93 (m, 4 H), 2.61 (m, 4 H), 2.32 
(m, 1 H), 1.82–1.73 (m, 4 H), 1.60 (d, 1 H), 1.24 (t, J = 9.4 Hz 4 H), 
1.11 (m, 1 H). 13C NMR (126 MHz, d6-DMSO, ppm) δ 182.85, 161.70, 
161.31, 146.48, 137.59, 135.14, 131.71, 130.95, 129.93, 129.77, 
124.26, 124.18, 62.94, 49.49, 48.66, 28.76, 26.32, 25.76. FT-IR (KBr, ν, 
cm-1): 3424 (N–H…O); 3234 (N–H); 3110− 2940 (C–H, aromatic); 
2940− 2750 (C–H, aliphatic); 1730 and 1682 (C–O, imide); 1598 
(N–O); 1538 (N–H); 1511 (C–C aromatic). 
The syntheses and characterization of thiosemicarbazides (Tc: 1–10) 
and corresponding thiosemicarbazones other than NITs (TSC) are pre-
sented in supplementary materials. 
2.3. Studies of the complexing properties 
2.3.1. Studies of the effect of a solvent on chelation 
The chelating behavior was tested in various solvents (acetone-AC, 
acetonitrile-ACN, methanol-MeOH, 0.1 M phosphate buffer-PBS) in an 
equimolar ligand-metal ratio. First, 1 mM salt solutions (chloride cations 
such as Cu2+, Fe3+) were prepared before use in the following way: 
appropriate weights of a salt were transferred quantitatively into a 
10 mL volumetric flask, which were then filled to the mark with distilled 
water. Next, the selected compounds (NITs 6, 8, 9 and TSCs 6b, 8e, 9f) 
were weighed (1 mg) and dissolved in DMSO to obtain a concentration 
of 1 mM. Then, 0.1 mL of the appropriate cation solution and 0.1 mL of 
the test compound solution were added into the 10 mL volumetric flask. 
The flask was supplemented to the mark with various solvents and 
mixed. The solution was left for four hours, after which the absorbance 
was measured. The obtained results from the entire series of cations for a 
given compound were normalized in the same wavelength range to more 
accurately analyze any changes in the absorption spectrum. 
2.3.2. General procedure for the titration 
The titration of a compound with Cu2+ or Fe3+ ions was performed in 
a MeOH/PBS* (9:1, v/v) system. In the studies, 1 mM solutions of the 
Cu2+ and Fe3+ salts and 1 mM solutions of the respective compounds in 
DMSO (NITs, TSCs, Dp44mT). which had been prepared as described in 
section 2.3.1, were used. Next, 5 mL of the MeOH/PBS (9:1, v/v) 
mixture was added to the thirteen volumetric flasks (10 mL). The twelve 
flasks were divided into two series of six, and the appropriate cation 
volumes that corresponded to 0.05, 0.1, 0.15, 0.2, 0.3 and 0.4 mL were 
added to each series (first series – Cu2+ cation, second series – Fe3+ ions). 
Then, 0.1 mL of the tested compound was added to all thirteen flasks and 
supplemented with MeOH/PBS (9:1, v/v) to the mark. The prepared 
solutions were mixed and then allowed to stand for some time. The 
absorbance was measured two hours after the solutions were prepared. 
A separate titration series with a metal was preformed according to the 
above procedure for each compound. 
* A 0.1 M solution of PBS, which was obtained by diluting the 
concentrate in distilled water, in the was used studies. 
2.4. Biological studies 
2.4.1. Cell cultures 
The human colon carcinoma cell line HCT 116 wild type (p53+/+) 
and human breast carcinoma cell line MCF-7 were purchased from the 
ATCC. The human colon cancer cell line HCT 116 with a p53 deletion 
(p53− /− ) was kindly provided by prof. M. Rusin from the Maria 
Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology in 
Gliwice, Poland. All of the cell lines were grown as monolayer cultures in 
75 cm2 flasks (Nunc) in Dulbecco’s modified Eagle’s medium, which 
was supplemented with 12 % heat-inactivated fetal bovine serum and a 
mixture of standard antibiotics – 1% v/v of streptomycin and penicillin 
(all of the reagents were purchased from Sigma-Aldrich). The cells were 
cultured under standard conditions at 37 ◦C in a humidified atmosphere 
at 5% CO2. Prior to beginning the experiments, all of the cell lines were 
subjected to routine mycoplasma testing with the specific Mycoplasma 
primers using the PCR technique. 
2.4.2. Cytotoxicity studies 
The HCT 116 and MCF-7 cells were seeded on 96-well transparent 
plates (Nunc) at a density of 5⋅103 cells per well and incubated under 
standard conditions at 37 ◦C for 24 h. Then, the growth medium was 
replaced with a medium containing the tested compounds at varying 
concentrations. The stock solutions of the compounds being investigated 
were prepared in sterile DMSO. The final concentration of DMSO in the 
medium did not exceed 0.2 %. After a 72-h incubation with the tested 
compounds, the media solutions were replaced with 100 μL DMEM 
(without serum and phenol red) and 20 μL of a CellTiter 96® AQueous 
One Solution reagent – MTS (Promega) and incubated for 1 h at 37 ◦C. 
The absorbance of the samples was measured at 490 nm using a Synergy 
4 multi-plate reader (BioTek). The results are expressed as the per-
centage of the control (untreated cells) and were calculated as the 
inhibitory concentration (IC50) values using GraphPad Prism 7. Each 
compound was tested in triplicate in a single experiment with each 
experiment being repeated at least three times. 
2.4.3. Evaluating the chelating ability in vitro – Calcein-AM assay 
The HCT 116 and MCF-7 cell lines were seeded into 96-well plates 
(Black, Clear Bottom, Corning) at a density 104 cells/well for 24 h before 
the experiment. The next day, the growth medium was removed and the 
cells were washed twice with a serum- and phenol red-free medium 
(Sigma-Aldrich). Then, the cells were loaded with 20 μM ferric- 
ammonium citrate (FAC, Sigma-Aldrich) for 4 h and washed three 
times with a medium without the serum and phenol red. Afterwards, the 
cells were loaded for 30 min with 0.25 μM of a cell-permeable acetox-
ymethyl ester of calcein (Calcein-AM, ThermoFisher) and washed three 
times with the medium (serum- and phenol red-free). The chelators 
(TSC-10a and Dp44mT) were added at a concentration of 25 μM. Fluo-
rescence intensity (λex – 488 nm; λem – 520 nm) was then conducted for 
25 min (measured at intervals of 60 s) at 37 ◦C using a Synergy 4 multi- 
plate reader. The results are expressed as the ratio of the maximum 
fluorescence intensity at each time point (Fn) to the maximum fluores-
cence intensity in the absence of the chelators (F0). All of the experi-
ments were repeated three times in triplicate and the results are 
expressed as the mean ± standard deviation (SD). 
3. Results and discussion 
3.1. Synthesis and characterization 
The presented NIT thiosemicarbazones were synthesized by 
condensing the selected thiosemicarbazides with 3-nitro-1,8-naphthalic 
anhydride. This is a new approach for synthesizing TSCs analogues. 
Fig. 1 shows the structures of the NIT and TSCs (thiosemicarbazones). 
The synthesis and characterization of the respective novel thio-
semicarbazides (Tc) and thiosemicarbazones (TSCs) is described in the 
supplementary materials. The data for all of the other compounds that 
were not described here are available in previous publications [12,17, 
18]. 
The obtained 3-nitro-1,8-naphthalene thiosemicarbazones were 
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purified by crystallizing them in ethyl acetate. The chemical structure of 
the obtained compounds was characterized using nuclear magnetic 
resonance (1H and 13C NMR, COSY and HMQC) and infrared spectros-
copy (FTIR). The 1H, 13C NMR and FTIR spectra of all of the compounds 
are presented in Figures S2-S4 in the SI, while the characteristic signals 
that were assigned to the same part of molecules are presented in Fig. 2. 
The correlation spectra such as COSY and HMQC for NIT-5 in DMSO 
were used to assign the signals (Figure S2 in the ESI). A single signal in 
the range of δH 10.43–10.61 ppm in the 1H spectrum indicates the 
presence of a H–N proton (a secondary amine). This proton is connected 
to a nitrogen atom (secondary amine) as was indicated by the COSY 
spectrum. Furthermore, a lack of a correlation with the carbon atom in 
the HMQC spectrum was also revealed. The high displacement values 
may indicate the occurrence of a hydrogen bond between N–H… O–C 
in the imide group (Figure S3 in the ESI). The presence of hydrogen 
bonds was confirmed by the FTIR spectrum, in which a band in the range 
of 3320− 3654 cm− 1 occurred. 
Based on the COSY and HMQC spectra, the signals from the protons 
(1H) and carbons (13C) could be precisely assigned to the structure of the 
compounds. The signals in the rangers: (a) 9.58− 9.56 ppm, (b) 
9.04− 9.02, (c and e) 8.88− 8.87 and 8.77− 8.74 ppm and (d) 
8.12− 8.12 ppm were assigned to the five protons in the aromatic ring of 
naphthalimide (Figures S2- S3 in the ESI). Similarly, the signals of the 
ten carbon atoms were assigned as follows (Figures S2 and S4 in the 
ESI): (3) 146.45–146.49 ppm, (6 and 8) 137.59–137.63 and 
135.18− 135.14 ppm, (2) 131.70–131.72 ppm, (7) 131.00− 130.95 ppm, 
Fig. 1. Structures of the NIT and TSC analogs.  
Fig. 2. The characteristic signals (1H, 13C, FTIR) that were assigned from the 
same parts of molecules. 
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(1 and 9) 129.95− 129.92 and 129.79− 129.77 ppm, (5 and 10) 
124.30− 124.26 and 124.23− 124.15 ppm and (4) 122.90− 122.81 ppm. 
The other signals that are typical for the aromatic range in both the 1H 
and 13C NMR spectra originated from the group that was attached to the 
six-membered imide ring. In addition, a signal above 180 ppm corre-
sponding to the group C–S was visible in all of the 13C spectra. A 
characteristic signal for the carbon in nitrile group at 89.61 ppm that is 
typical for the absorption of CN at 2213 cm− 1 was detected in the 13C 
NMR and FTIR spectra of the NITs-1 compound. The type of atom (X–N, 
C or O) as well as the substituent (R) influenced the conformation in the 
six-membered saturated heterocyclic, e.g. the piperazine [27], mor-
pholine [28] or piperidine [29–31] ring. Molecules that have hetero-
cyclic rings usually adopt chair conformations (lowest energy) but with 
a different axial or equatorial position of the substituent (Fig. 3). 
3.2. Optimizing the compound structures 
The theoretical calculations were performed using the density 
functional theory (DFT) and were carried out using the Gaussian09 
program [33] on the B3LYP/6− 31g++ level [34,35]. The molecular 
geometry of the singlet ground state of the compounds was optimized in 
the gas phase and its electronic structures and electronic transitions 
were calculated using the Polarizable Continuum Model (PCM) with 
methanol as the solvent. Such calculations were carried out to analyze 
the structure of the frontier molecular orbitals and energy levels and the 
UV–vis data. The optimized geometries of the compounds are depicted 
in Figures S5 and S6 in the Supplementary Information, which presents 
the experimental and calculated IR spectra. The piperidine (NIT-3), 
morpholine (NIT-7) and piperazine (for all others) fragments had a chair 
conformation. The geometrical parameters of the amine N–H and 
amide carbonyl group indicated the possibility of a hydrogen bond with 
a H⋯O distance 2.3–2.4 Ǻ and an N–H…O angle in the range of 
96◦-101◦. A second intramolecular hydrogen bond is possible between 
C–S and piperazine, morpholine or piperidine C–H with a distance 2.5 
Ǻ and a C–H…S angle close to 113◦. The calculated hydrogen bond 
vibrations corresponded to the experimental data well as can be seen in 
Figure S7. The frontier molecular orbitals of the compounds were 
characterized based on the optimized geometries. In order to obtain a 
detailed description of the molecular orbitals, the contribution of the 
parts, i.e. 3-nitro-naphthalene, HN-CS- and substituted six-membered 
saturated ring fragments to a molecular orbital, were calculated. The 
obtained DOS diagrams are depicted in Figure S8 and the composition of 
the selected molecular orbitals in the ground state are listed in Table S1 
in the ESI. The electronic structures of the compounds were similar and 
LUMO in each case was localized on the 3-nitro-naphthalene part, and 
therefore the changes in the energy of this level were negligible. The 
HN-CS- fragment played a dominant role in the HOMO of NITs-3 and 
NITs-7, that is, in the case of the compounds in which the six-membered 
saturated heterocyclic ring was substituted with piperidine or, as in the 
case of NIT-7, unsubstituted morpholine. In other cases, the HOMO was 
localized on the substituent of the six-membered saturated ring with the 
exception of NIT-4 where the share of HN-CS- was significant. The thi-
osemicarbazide (HN-CS-) part played a dominant role in the H-1 to H-5 
levels, which is important for interpreting the lowest energy band on the 
UV–vis spectra. In the energy range that corresponded to the first, lowest 
energy, the band on the electronic absorption spectrum was calculated 
H-2/3 → LUMO transitions, which corresponded to the excitation be-
tween the nonbonding orbitals that were localized on the 
S–C-(saturated six-membered ring) and 3-nitro-naphthalene. 
3.3. Complexing the properties of the compounds 
The ability to complex Cu2+ or Fe3+ ions may prove to be the key to 
explaining the cytotoxicity of drugs [1]. Therefore, we decided to 
measure and analyze the complexing properties of the tested com-
pounds. First, the influence of the solvent such as acetone (AC), aceto-
nitrile (ACN), methanol (MeOH) and 0.1 M PBS on the complexation 
was investigated for the selected compounds (NITs 6, 8, 9 and TSCs 6b, 
8e, 9f) at an equimolar ratio of thiosemicarbazone and metal (Figure S9 
in the ESI). These studies revealed that the PBS solution significantly 
affected the Cu2+ complexation by TSC-6b and TSC-8e, and to a small 
extent, on the Fe3+ complexation by TSC-8e. On the other hand, meth-
anol had a beneficial effect on the complexation of both the Cu2+ and 
Fe3+ ions. It was also observed that TSC-6b and TSC-8e had a good af-
finity for the Cu2+ ions, which was slightly weaker for Fe3+, whereas the 
complexing properties of TSC-9f, NIT-6, NIT-8 and NIT-9 were negli-
gible. In our spectroscopic experiments, phosphate buffered saline was 
used to reflect the environment of a biological system. 
However, it appears that the presence of the phosphate groups in a 
PBS buffer may have a significant impact on the binding of metal ions 
and other molecules as has been presented in few reports [36–38]. 
However, the influence of the other solvents (AC, ACN) on complexation 
was insignificant, and therefore, they were omitted in the following part. 
These data may suggest that the complexation of metals by the tested 
TSCs are dependent on the character of the solvent as the effect was 
more visible in the polar protic solvent – methanol. Based on these re-
sults, further studies were performed of the complexing properties in the 
MeOH/PBS (9:1, v/v) system. In this way, we limited the possible in-
teractions of the sodium phosphates with metal ions, which may affect 
the final results of TSC experiments with complexing metal ions in a 
solution. Thus, these studies will allow the ability of the compounds to 
complex Cu2+ or Fe3+ ions to be compared and their biological prop-
erties to be discussed. For this purpose, the metal titration (5− 40 μM) of 
the compounds was performed in the MeOH/PBS (9:1, v/v) system. The 
superimposed spectra of the spectroscopic changes that were caused by 
the addition of various amounts ions is presented in Figs. 4 and 5 and 
Figures S10 - S11. Furthermore, the changes that resulted from the 
addition of an equimolar amount of a metal for all of the compounds 
tested is presented in Figures S12 to S14, whereas the spectroscopic 
data are collected in Table 1. 
Two characteristic bands are visible in the UV–vis spectrum for the 
pure compounds (blue line). The first band in the range of 240–300 nm 
corresponds to the part thiosemicarbazone (C–S) with an unsaturated 
six-membered ring, while the second band in the range from 300 to 
400 nm could have been caused by the n-π* transitions in the substituent 
a–f (Fig. 1, derivatives of pyridine, quinoline or aryls) [39] or in the 
imide unit [40–42] (see Table 1.). Importantly, observing changes in 
these regions may enable to localize the site of Cu2+ or Fe3+ ions Fig. 3. Possible conformers and their interchange [28,31,32].  
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complexation by compounds to be determined. Moreover, the changes 
in absorption spectra as well as forming of isosbestic points caused by 
complexation of Cu(II) and Fe(III) ions are clearly seen. It can be noticed 
that the isosbestic points are located at similar values (irrespective of R 
substituent or the type of cation), e.g. for derivatives with 3-aminopyr-
idine (TSC: 2b, 3b, 4b, 5b, 6b) points occur at ≈ 290, 335 and 395 nm 
(see Table 1). In addition, the superimposed UV–vis spectra of metals 
titration was used to determine ratio of ligand: metal and the corre-
sponding values are shown in Table 1. The ligand to metal ratio in most 
of the examples is 1: 1.5, which indicates the possibility of forming 
cluster complexes [43], for example complex consists of of 2 ligands and 
a 3 metal center to form the [M3L2] model [44,45]. The formation of 
such systems may be favored by additional donor centers present in the 
structure of six-membered saturated heterocyclic [46]. In Fig. 4, the 
results from the metal titration are presented taking into account the 
effect of the different substituents (NITs and b, e, f as show in Fig. 1) on 
the ability to form complexes. We observed that the TSC-6b and TSC-8e 
had the ability to form complexes with Cu2+ and Fe3+ ions in contrast to 
TSC-9f. This is due to the presence of the pyridine (TSC-6b) and hydroxyl 
(TSC -8e) groups in these molecules. It was found that the presence of 
the nitro group (TSC-9f, NIT-6, NIT-8 and NIT-9) limited the complexing 
ability. In addition, Figure S13 presents the superimposed spectra of the 
compounds that contained the (4-cyanophenyl)piperazine unit (TSC: 1a, 
1b, 1c, 1d, NIT-1) relative to the Cu2+ and Fe3+ ions at an equimolar 
ratio. The clearly visible spectral changes, which were associated with 
the Cu2+ and Fe3+ complexation, can be identified for TSCs: 1a and 1b, i. 
e. the compounds that contain nitrogen within the ring. 
However, the changes in the spectra for the compounds that have the 
− OH group (TSC: 1c, 1d) indicated that chelation mainly involved Cu2+. 
In turn, the Fe3+ complexation was less visible than in the case of the 
heteroaryl derivatives. Whereas, the compounds that had the 3-nitro- 
1,8-naphthalene (NITs) substitution did not show any spectroscopic 
transformations, thereby indicating a lack of complexing ability against 
Cu2+ and Fe3+. A comparison of the studied TSCs and NITs indicated 
that the latter lacked of a complexing ability, which may be attributed to 
the steric hindrance within the large naphthalimide unit. The results for 
NITs 2, 3, 4, 5, 6 compared to the TSC with 3-aminopyridine group are 
presented in Figure S12 in the ESI, additionally they confirm it. Due to 
the visible difference in the complexing ability of the Fe(III) ions by 
thiosemicarbazones (TSC), the further part of this work focuses on 
explaining this relationship. 
Thiosemicarbazones with metals, depending on the structure and 
number of ligands (L), generally can form mono- or bis- complexes [47]. 
In these systems, the complexation occurs through a sulfur atom, ni-
trogen (imine) and nitrogen atoms present in quinoline or 3-aminopyr-
idine [48]. Whereas, in derivatives with a 2-hydroxyphenyl group, the 
complexation may occur via an oxygen atom [49]. 
Therefore, the TSCs coordinate the cation by means of N (imine), S 
and when an additional coordinating group is present (O, N) may 
include the typical tridentate coordination fashion (Fig. 5a). Moreover, 
it was shown that the Fe(III) forms high stable mono and bis complexes 
with Triapine bearing the well-known (Npyridine, N, S− ) coordination 
mode and [Fe(III)L2]+ predominates at pH 7.4 [50]. Moreover, for de-
rivatives with salicyl aldehye unit at pH = 7.4 species [Fe(III)L2]− are 
predominated [39]. As shown by recent studies the method binding of 
the metal cations by the third atom (O or N) may be crucial for the 
properties of the metal-complex. On the example of cobalt complexes, 
greater catalytic activity of the complex with the pyridine group than 
with the quinoline group was proved, pointing to the important roles of 
both the electronic and steric effects of a substituent. Moreover, a cor-
relation between the basicity of nitrogen in aromatic amines (pyridine, 
quinoline, isoquinoline) and the N-Metal bond length was described on 
the example of complexes with cobalt ions [51]. In addition, in the use of 
gold complexes, the influence of the pyridine substituent in complex on 
catalytic properties was noticed, which was directly related to the 
different coordination ability of the pyridine and quinoline nitrogen 
atoms. Based on these studies, selective coordination of pyridine nitro-
gen, whereas quinoline nitrogen atoms failed to undergo complexation 
was found [52]. Based on those reports we analyzed the effect of the 
substituent (pyridine, quinoline, 2-hydroksyfenol) at the imino bond on 
the ability of complexing iron (Fig. 5). Basicity of nitrogen atom in pure 
3-aminopyridine (pKa = 5.98) is higher than in quinoline (pKa = 4.85) 
[53,54]. Moreover, the calculated pKa values of imine nitrogen show the 
reduction of the basicity of the imine nitrogen in series TSC-1b (13.32) >
TSC-1a (12.77) > TSC-1c (9.44) (ESI section 1.3). Thus, it is expected 
that higher basicity of nitrogen atoms (Nimine, NAr) for TSC-1b favor the 
formation of a more stable iron complex than for TSC-1a or TSC-1c 
(Fig. 5). Analyzing Fig. 5 for the TSC-1b derivative, the changes as the 
Table 1 
The spectroscopic data of tested compounds and its complexes with Cu(II) or Fe(III).  
code 




λmax [nm] λmax [nm] Isosbestic point [nm] λmax [nm] Isosbestic point [nm] 
NIT-1 284, 330sh – – – – – – 
TSC-1a 290, 350 296, 360, 453 363 1:1 290, 360, 417 368 1:1 
TSC-1b 290, 370 297, 448 335, 395 1:1.5 294, 432, 490sh 337, 390 1:1.5 
TSC-1c 295, 341 294, 330sh,402 307, 339, 353 1:1.5 295, 385sh – – 
TSC-1d 294, 335sh 295, 327sh,392 308, 343 1:1.5 294, 377sh – – 
NIT-2 280sh, 328 – – – – – – 
TSC-2b 256, 370 256, 294, 370, 448 283, 335, 396 1:1.5 256, 380, 440, 490sh 288, 335, 392 1:1.5 
NIT-3 278sh, 330 – – – – – – 
TSC-3b 264, 373 295, 377, 450 282, 336, 396 1:1.5 309, 430, 490sh 288, 338, 390 1:1 
NIT-4 272, 328 – – – – – – 
TSC-4b 267, 372 270, 297sh, 375, 446 286, 336, 395 1:2 266, 308sh, 381, 450sh, 490sh 288, 337, 391 1:1.5 
NIT-5 278, 328 – – – – – – 
TSC-5b 283sh, 373 290, 373, 450 283, 336, 397 1:1.5 308, 383, 440sh, 490sh 289, 337, 393 1:1.5 
NIT-6 280, 328 – – – – – – 
TSC-6b 296sh, 371 300, 451 289, 328, 400 1:1.5 304, 437, 492sh 296, 344, 394 1:1.5 
NIT-7 278, 328 – – – – – – 
TSC-7c 284, 339 280, 329, 402 267, 306, 340, 354 1:1.5 281, 337, 388 – 1:4** 
NIT-8 277, 330 – – – – – – 
TSC-8e 279, 330 324, 347, 375, 392sh 276, 310, 347 1:1.5 306, 364 – – 
NIT-9 284sh, 328 – – – – – – 
TSC-9f 295, 345sh 308, 390sh – – – – – 
TSC-10a 286, 312, 337, 352sh 289sh, 312, 378, 445 – 1:3 286, 312, 337, 352sh, 422 – 1:4** 
Medium: MeOH:PBS (9:1, v/v); c = 10− 5 mol/dm3; sh-shoulder; *- maximum L: Me ratio above which there were no visible changes in the spectrum, determined on the 
basis of the UV–vis spectra titration with metals, presented in Fig. 4 and Figures S10 and S11 in ESI; **- studies were not conducted above this L: Me ratio (1: 4). 
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amount of iron increases include the complete reduction of the band in 
the range of 325–380 nm and the formation of the new band in the range 
of 400 to 550 nm with the maximum absorption at 432 nm and the 
shoulder at 490 nm. Thus, changes in this range are evident for each 
derivative with 3-aminopyridine (Fig. S10-S11), which is probably 
related to the better complexation of iron ions by the more basic ni-
trogen atoms. Whereas, in the case of TSC-1a, the changes in the UV–vis 
spectrum include the partial reduction of the band in the range 
320− 370 nm (with λmax = 350 nm) and the formation a new band in the 
range 375− 500 nm. It can be seen that the band with λmax = 350 nm 
does not disappear completely. We can suppose that the result of a 
weaker interaction nitrogen atoms with iron ion, as was in the case with 
the Co(II) [51] or Au(III) [52] complexes. In the third case, for a TSC-1c 
derivative with a 2-hydroxyphenyl group, the changes in the spectrum 
include slight increase of the band in the range of 330–420 nm without 
distinct shaping of the λmax. The main reason for such changes may be 
steric hindrance which may reduce the possibility of complexing iron 
ions. Other TSC derivatives with hydroxyl or nitro groups (1c, 1d, 7c, 8e, 
9f) had a weaker or no ability to coordinate the Fe3+ ions. The above 
considerations were supplemented with DFT calculations. The bonding 
properties and energy analysis were made for the Fe-thiosemicarbazone 
complexes [ML2]. The Wiberg indices and the bond distances of Fe-L are 
similar in the complexes to provide descriptions of ligands bonding in 
the complexes the fragmentation model according to the energy depo-
sition (EDA) scheme was chosen (cf. ESI Tables 2–4). The calculated 
interaction energies collected in Table S4 and the total energy ΔEint is 
mainly determined by the TSC ligand. Only in the case of Fe-Tsc-1b the 
ΔEelect and ΔEPauli components compensate each other and the repulsive 
term has a significant advantage over the electrostatic interaction. This 
indicates that the [FeL2] +→ [FeL]2+ + L– process is not preferable. The 
total attractive interactions ΔEelect + ΔEorb are rather high and play a 
meaningful role in the binding interactions in Fe-TSC-1b and TSC-1a 
complexes. In the case of Fe-Tsc-1c compound the attractive compo-
nent is practically compensated by repulsion factor so the stability of this 
compound is small. Moreover, the calculated steric factor contained in 
ΔEPauli (ESI Table 4) is the highest for the Fe-TSC-1c and confirms the 
above statement. 
The TSC analogs, which are presented in Figure S10 and S11, show 
the pronounced changes in a spectrum in the range of 220− 250 nm, 
especially in the complexation of Cu2+ ions. Therefore, in the next part, 
we analyzed the impact of the unsaturated six-membered ring in the TSC 
on metal ion complexation. The analysis for the compounds that 
Fig. 4. UV–vis absorption titration spectra of the investigated compounds (10 μM) with Fe3+ (M) and Cu2+ (M) (5-40 μM) in a MeOH/PBS (9:1, v/v) mixture at room 
temperature two hours after it had been prepared. 
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contained pyridine, piperazine, morpholine and thiomorpholine is pre-
sented in Figure S11. It was found that the type of substitution (by a 
donor atom: N, O, S or C) did not significantly affect the chelation 
ability. Based on this, we can conclude that the second heteroatom (next 
to nitrogen at the para position) in the unsaturated six-membered ring 
does not participate in copper or iron complexation. On the other hand, 
it was observed that the TSCs with both a heteroaryl and an − OH group 
chelated the Cu2+ ions easily. This was visible for each substituent on the 
imine bond (Figs. 4 and S10-S11). In addition, for the Cu2+ chelation, 
changes that ranged from 240–300 nm were observed, which indicates a 
complexation between Cu2+ and –C–S and the adjacent nitrogen atom. 
No similar effect was observed for the Fe3+ chelation. Moreover, the o- 
hydroxyphenyl imines are known for their good copper chelation 
properties [55–57]. Although the unsaturated six-membered ring did 
not create the coordination band with metal, it undoubtedly had an 
impact on the biological activity that affected the lipophilicity or other 
specific interactions with a receptor. In our previous in vitro studies, we 
showed that highly active thiosemicarbazone derivatives have a better 
chelation ability to form complexes with Cu2+, which correlated well to 
their therapeutic response [12,17]. This corresponds to the results of 
Stacy et al. who demonstrated that the complexes Dp44mT with copper 
can generate larger amounts of ROS, which induces a Pgp-dependent 
lysosomal membrane permeabilization, thereby increasing cytotoxicity 
and overcoming multi-drug resistance [57]. Additionally, it should not 
be forgotten that Cu2+ chelation by TSCs is a complex phenomenon that 
involves ionophoric effects, i.e. the ability to transport metal ions 
through the cell membranes. This intrinsic mechanism of TSCs enables 
the concentration of metal in the cellular environment to be increased, 
which causes a disturbance of cell homeostasis and its damage. 
3.4. Anticancer activity 
The results of the anticancer antiproliferative activity of the studied 
compounds are presented in Table 2. We performed cytotoxicity assays 
against two human colon cancer cell lines: the wild type (HCT 116 p53+/ 
+) and negative p53 (HCT 116 p53− /− ) and the human breast cancer cell 
line (MCF-7). The selection of those cell lines was related to the fact that 
colon and breast tumors are characterized by an increased iron uptake, 
cell metabolism and sensitivity to redox changes. Generally, all of the 
tested TSCs had a strong or weak activity, while NITs were inactive 
against all of the cancer cell lines. This corresponds well to the chelating 
ability of the tested TSCs and NITs. The aminopyridine derivative TSC- 
2b had the highest activity among the tested compounds (the IC50 values 
were 0.14 μM for HCT 116 p53+/+ and 0.20 μM for MCF-7). In addition, 
it is worth noting that the TSCs with the aminopyridine substituent 
(TSCs 1b, 3b, 4b, 5b, 6b) also had a excellent activity with IC50 values 
that ranged from 0.14 μM to 1.9 μM for both of the HCT 116 cell lines. 
Apparently, a good activity of the aminopyridines correlates with the 
better chelation ability of the Fe3+ ions as was observed in the spec-
troscopic studies (Figs. 4 and 5). The rest of the TSCs had low activity 
values of IC50 in the range of 7.76 μM to 20.43 μM for the HCT 116 cells. 
The exceptions were TSC-1a and TSC-1c, which had a good/moderate 
activity. There was similar trend for the MCF-7 cells, which was 
consistent with the spectroscopic analysis of the Fe3+ chelation. 
Fig. 5. a) The proposed model of iron cation binding on the example of a [FeL2] complex, including ligands: Tsc - 1a, 1b, 1c by neutral pH and R = 4-cyanophenyl 
group; b) UV–vis absorption titration spectra of the investigated compounds (10 μM) with Fe3+ (5-40 μM) in a MeOH/PBS (9:1, v/v) mixture. 
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In the next step, we examined the ability of the TSCs to complex the 
iron ion at the cellular level. For the intracellular iron binding assay, 
which is based on a measurement of the calcein fluorescence intensity, 
we selected two derivatives: the highly active – Dp44mT and the 
moderately active – TSC-10a. As is presented in Fig. 6, there was a sig-
nificant increase in the calcein fluorescence after the Dp44mT treat-
ment. This effect may have been associated with a decrease in the labile 
iron pool, which confirms the high efficiency of the intracellular iron 
chelation of Dp44mT on both cell lines. On the other hand, as was ex-
pected, a much smaller effect was observed for TSC-10a. In addition, the 
small differences in the fluorescence intensity that was observed be-
tween the tested cell lines appear to correlate with the anticancer ac-
tivity of TSC-10a (IC50: 18.31 μM for HCT 116 p53+/+ and more than 25 
μM for MCF-7). These observations confirm the overall relationship 
between the anticancer activity and chelating properties of the TSCs. 
Importantly, similar dependences were recorded in our previous studies 
on uptake and mobilization of iron from cells [16,59]. In general, we 
indicated that the TSCs that are based on the di-2-pyridine ketone 
moieties had better ability to bind cellular Fe3+ than their quinoline 
analogs. In turn, this could be correlated with the improvement of the 
cytotoxicity of the corresponding compounds. An interesting example 
was the quinoline derivative that had been substituted with a morpho-
line ring, which was characterized by both a weak anticancer activity 
and the ability to mobilize cellular iron compared to its 8-hydroxyquino-
line analog that had a high anticancer potency [16,60]. 
4. Conclusion 
A broad study of the chelating behavior of a series of TSCs and NITs 
compounds demonstrated that the efficient complexing of Cu2+ and 
Fe3+ ions has a significant influence on the biological activity of the 
tested compounds. Because metal ions play an important role in the 
cellular processes, a disturbance in their natural homeostasis has a 
critical impact on a cell. In this work, we did an in-depth analysis of the 
chelating behavior of nine newly synthesized derivatives of NITs and 
TSC analogs. The synthetic pathway of the NITs is presented here for the 
first time. Detailed spectroscopic analyses in different solvents and 
conditions involving Cu2+ and Fe3+ ions permitted a comprehensive 
determination of the structural features that influence the complexation 
properties. Based on the UV–vis spectra titration with Fe3+ and theo-
retical calculations, the chelating ability for the TSC derivatives was 
analyzed. The stability of Fe(III)-complexes depends on the basicity of 
nitrogen atoms in the analyzed compounds. Therefore, the drivatives 
containing 3-aminopyridine may form more stable complexes with Fe3+
ions than with the quinoline substituent. In the case of derivatives in the 
hydroxyl group, steric hindrance and lower basicity of Nimine may affect 
the low stability of the complex with Fe3+ ions. Biological studies of the 
cytotoxicity on three cancer cell lines showed that the binding of metal 
ions is crucial for the anticancer activity of the tested compounds. The 
formation of a coordination bond with metal depends on an advanta-
geous arrangement of the donor atoms. 
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Table 2 
Anticancer properties of the tested compounds (NITs and TSCs) against the 
human colon and breast cell lines.  
Compounds Cytotoxicity [μM]  
HCT 116 p53+/+ HCT 116 p53− /− MCF-7 
NIT-1 >25 >25 >25 
TSC-1a* 0.56 ± 0.14 0.43 ± 0.03 0.23 ± 0.11 
TSC-1b* 1.45 ± 0.45 0.75 ± 0.35 3.81 ± 1.02 
TSC-1c 5.30 ± 1.33 1.41 ± 0.43 3.33 ± 0.38 
TSC-1d 15.87 ± 5.97 8.33 ± 1.37 9.98 ± 1.61 
NIT-2 >25 >25 >25 
TSC-2b* 0.12 ± 0.01 0.17 ± 0.02 0.20 ± 0.05 
NIT-3 >25 >25 >25 
TSC-3b 0.14 ± 0.02 0.28 ± 0.01 0.23 ± 0.04 
NIT-4 >25 >25 >25 
TSC-4b* 0.17 ± 0.02 0.16 ± 0.01 0.26 ± 0.04 
NIT-5 >25 >25 >25 
TSC-5b* 0.67 ± 0.05 0.65 ± 0.06 1.73 ± 0.39 
NIT-6 >25 >25 >25 
TSC-6b* 1.90 ± 0.29 0.14 ± 0.02 1.12 ± 0.11 
NIT-7 >25 >25 >25 
TSC-7c 19.24 ± 2.94 7.76 ± 1.57 16.55 ± 1.04 
NIT-8 >25 >25 >25 
TSC-8e 11.36 ± 4.69 9.37 ± 0.65 >25 
NIT-9 >25 >25 >25 
TSC-9f* 11.78 ± 3.28 20.43 ± 2.29 >25 
TSC-10a* 18.31 ± 0.92 5.85 ± 0.45 >25 






The structures of the tested compounds are presented in Fig. 1. 
* The compound described in the publication: TSC-1a [12]; TSC: 1b, 2b, 4b, 
5b, 6b [18] and TSC: 9f, 10a [58]. 
Fig. 6. The intracellular chelating properties of Dp44mT and TSC-10a (25 μM) after FAC (20 μM) loading in the HCT 116 (A) and MCF-7 (B) cell lines. Cells that had 
not been treated with chelators were the control. The chelators were administered in the 10th minute of the measurement. 
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